DE60038119D1 - Dendritische zellen, aktiviert in anwesenheit von glucocorticoiden hormonen, sind in der lage, die antigenspezifische t-zell-antwort zu unterdrücken - Google Patents

Dendritische zellen, aktiviert in anwesenheit von glucocorticoiden hormonen, sind in der lage, die antigenspezifische t-zell-antwort zu unterdrücken

Info

Publication number
DE60038119D1
DE60038119D1 DE60038119T DE60038119T DE60038119D1 DE 60038119 D1 DE60038119 D1 DE 60038119D1 DE 60038119 T DE60038119 T DE 60038119T DE 60038119 T DE60038119 T DE 60038119T DE 60038119 D1 DE60038119 D1 DE 60038119D1
Authority
DE
Germany
Prior art keywords
cell
antigen
specific
dendritic cells
activated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60038119T
Other languages
English (en)
Other versions
DE60038119T2 (de
Inventor
Delphine Gabrielle Rea
Cornelis Johannes Melief
Rienk Offringa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leids Universitair Medisch Centrum LUMC
Original Assignee
Leids Universitair Medisch Centrum LUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leids Universitair Medisch Centrum LUMC filed Critical Leids Universitair Medisch Centrum LUMC
Application granted granted Critical
Publication of DE60038119D1 publication Critical patent/DE60038119D1/de
Publication of DE60038119T2 publication Critical patent/DE60038119T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464402—Receptors, cell surface antigens or cell surface determinants
    • A61K39/464416—Receptors for cytokines
    • A61K39/464417—Receptors for tumor necrosis factors [TNF], e.g. lymphotoxin receptor [LTR], CD30
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464476—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/05—Adjuvants
    • C12N2501/052—Lipopolysaccharides [LPS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/505—CD4; CD8
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60038119T 1999-10-04 2000-10-04 Dendritische zellen, aktiviert in anwesenheit von glucocorticoiden hormonen, sind in der lage, die antigenspezifische t-zell-antwort zu unterdrücken Expired - Lifetime DE60038119T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15744299P 1999-10-04 1999-10-04
US157442P 1999-10-04
PCT/NL2000/000712 WO2001024818A1 (en) 1999-10-04 2000-10-04 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses

Publications (2)

Publication Number Publication Date
DE60038119D1 true DE60038119D1 (de) 2008-04-03
DE60038119T2 DE60038119T2 (de) 2009-02-26

Family

ID=22563732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60038119T Expired - Lifetime DE60038119T2 (de) 1999-10-04 2000-10-04 Dendritische zellen, aktiviert in anwesenheit von glucocorticoiden hormonen, sind in der lage, die antigenspezifische t-zell-antwort zu unterdrücken

Country Status (11)

Country Link
US (1) US7560105B1 (de)
EP (1) EP1218028B1 (de)
AT (1) ATE386539T1 (de)
AU (1) AU1062501A (de)
CA (1) CA2388229A1 (de)
CY (1) CY1107952T1 (de)
DE (1) DE60038119T2 (de)
DK (1) DK1218028T3 (de)
ES (1) ES2301494T3 (de)
PT (1) PT1218028E (de)
WO (1) WO2001024818A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038699A1 (de) * 2000-07-31 2002-02-14 Michael Sittinger Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten
FR2826975B1 (fr) * 2001-07-09 2004-06-04 Bio Merieux Utilisation de lipoproteines oxydees pour obtenir la differenciation de monocytes en cellules dendritiques matures
US7727523B2 (en) * 2001-08-13 2010-06-01 Yale University Method for suppressing immune system response to transplanted tissue or cells
NZ570709A (en) * 2003-06-13 2010-04-30 Univ Pennsylvania Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
AU2011231558B2 (en) * 2010-03-26 2016-08-11 Westfaelische Wilhelms-Universitaet Muenster Substitute therapy for glucocorticoids

Also Published As

Publication number Publication date
EP1218028A1 (de) 2002-07-03
DK1218028T3 (da) 2008-06-23
DE60038119T2 (de) 2009-02-26
AU1062501A (en) 2001-05-10
ATE386539T1 (de) 2008-03-15
EP1218028B1 (de) 2008-02-20
CY1107952T1 (el) 2013-09-04
ES2301494T3 (es) 2008-07-01
PT1218028E (pt) 2008-07-10
US7560105B1 (en) 2009-07-14
WO2001024818A1 (en) 2001-04-12
CA2388229A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
Clark et al. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin
Li et al. IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8+ T cells
Shevach et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells
Gérard et al. LFA-1 in T cell priming, differentiation, and effector functions
Langenkamp et al. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification
Wijaya et al. HBV vaccination and HBV infection induces HBV-specific natural killer cell memory
White et al. Differential activation of CD 57‐defined natural killer cell subsets during recall responses to vaccine antigens
EP1150570A4 (de) Aktivierung von regulatorischen t zellen durch ein alpha-melanocyten stimulierendes hormon
CA2264925A1 (en) Purification of antigen-specific t cells
WO2004091543A3 (en) Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
IL161832A0 (en) Pharmaceutical composition for inducing an immune response in a human or animal
JP5161798B2 (ja) Ｔ細胞アッセイ
Dimitrov et al. Activated integrins identify functional antigen-specific CD8+ T cells within minutes after antigen stimulation
EP3084435A1 (de) Verfahren zur t-zellepitop-profilierung, zur herstellung von t-zell zusammensetzungen und zur behandlung von erkrankungen
Long et al. Functional islet‐specific Treg can be generated from CD4+ CD25− T cells of healthy and type 1 diabetic subjects
Jasiulewicz et al. Homeostatic ‘bystander’proliferation of human peripheral blood B cells in response to polyclonal T-cell stimulation in vitro
DE60038119D1 (de) Dendritische zellen, aktiviert in anwesenheit von glucocorticoiden hormonen, sind in der lage, die antigenspezifische t-zell-antwort zu unterdrücken
Shin et al. Recyclable cytokines on short and injectable polylactic acid fibers for enhancing T‐cell function
Blunt et al. Phenotypic characterization of bovine memory cells responding to mycobacteria in IFNγ enzyme linked immunospot assays
Higgins et al. Isotype-specific plasma cells express divergent transcriptional programs
US20090004742A1 (en) Selection of antigen-specific t cells
Fernandez et al. Peripheral NKT cells in simian immunodeficiency virus-infected macaques
WO2004084838A3 (en) Identification, quantification, and characterization of t cells and t cell antigens
Zanni et al. Involvement of T cells in drug-induced allergies
Weaver et al. Abortive activation of CD4 T cell responses during competitive priming in vivo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition